Experts at the 2025 Clinical Trial Supply Europe conference will explore supply chain challenges and the impact of AI on ...

Northwestern Medicine is a global leader in clinical trial research, including spine CLARITY is a randomized study designed ...

Qlaris Bio has reported positive topline outcomes from two Phase II US trials of QLS 111 in individuals with POAG and OHT.

NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing neurorestorative ...

Alys Pharmaceuticals has received clearance from the US FDA and Health Canada for a Phase IIa trial of ALY-101 for alopaecia ...

SAN FRANCISCO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- TrialWire, a leader in clinical trial recruitment innovation, launched its groundbreaking AI Voice Screen service as part of the TrialWire Recruitment ...

Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical-stage biotechnology company pioneering innovative cancer and viral infection treatments, today announced the ...

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on ...

Positive Enrollment Progress and Safety Data ~~ FDA Attention Establishes Momentum in the Pain Treatment Space ~ SAN DIEGO, CA / ACCESS Newswire / February 5, 2025 / Ensysce Biosciences, Inc.

The FDA’s approval for expanded use reinforces LP-310’s potential as a new therapeutic option for OLP and supports ongoing clinical development efforts.

Percheron Therapeutics says it will abandon its lead drug candidate altogether, following December's Duchenne muscular ...